Granules Pharmaceuticals Inc. recalled 11,895 bottles of extended-release capsules on August 28, 2025. The capsules failed impurities and degradation specifications. Consumers should stop using the product immediately, as it could pose health risks.
Failed Impurities/Degradation Specifications:
Consumers and healthcare providers should stop using this product immediately. Contact Granules Pharmaceuticals Inc. or your healthcare provider for guidance. Notification method: E-Mail
The recalled product is Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, 10 mg, 100 capsules per bottle. The recall affects lot number GPC250159A with an expiration date of June 22, 2027. It was distributed nationwide in the USA.
The product failed to meet impurities and degradation specifications set by regulatory standards. This failure can lead to potential health risks, including degradation of the medication's effectiveness.
No specific incidents or injuries related to this recall have been reported at this time. The recall is classified as high risk due to the potential health implications.
Consumers and healthcare providers should stop using the recalled capsules immediately. Contact Granules Pharmaceuticals Inc. or your healthcare provider for further guidance.
For more information, reach Granules Pharmaceuticals Inc. via email. Additional details can be found on the FDA's recall page.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.